The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice
Shapovalova VO, Mykhaĭlov VS, Shapovalov VV.
Abstract
There are studying the symptoms of development catalepsy at new home preparation, which is having the butirophenone's derivative. There are shown that the time development and manifestation of catalepsy are depending from preparation's dose: 0.1 mg/kg-1.3 mg/kg (maximum) -10 mg/kg in intravenous introduction and 1.2 mg/kg-3.5 mg/kg (maximum)-40 mg/kg in intraperitoneal introduction.
References
|
